Antagonists of growth hormone-releasing hormone receptor induce apoptosis specifically in retinoblastoma cells

Wai Kit Chu, Ka Sin Law, Sun On Chan, Jason Cheuk Sing Yam, Li Jia Chen, Hao Zhang, Herman S Cheung, Norman L Block, Andrew V Schally, Chi Pui Pang

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Retinoblastoma (RB) is the most common intraocular cancer in children worldwide. Current treatments mainly involve combinations of chemotherapies, cryotherapies, and laser-based therapies. Severe or late-stage disease may require enucleation or lead to fatality. Recently, RB has been shown to arise from cone precursor cells, which have high MDM2 levels to suppress p53-mediated apoptosis. This finding leads to the hypothesis that restoring apoptosis mechanisms in RBs could specifically kill the cancer cells without affecting other retinal cells. We have previously reported involvement of an extrapituitary signaling pathway of the growth hormone-releasing hormone (GHRH) in the retina. Here we show that the GHRH receptor (GHRH-R) is highly expressed in RB cells but not in other retinal cells. We induced specific apoptosis with two different GHRH-R antagonists, MIA-602 and MIA-690. Importantly, these GHRH-R antagonists do not trigger apoptosis in other retinal cells such as retinal pigmented epithelial cells. We delineated the gene expression profiles regulated by GHRH-R antagonists and found that cell proliferation genes and apoptotic genes are down- and up-regulated, respectively. Our results reveal the involvement of GHRH-R in survival and proliferation of RB and demonstrate that GHRH-R antagonists can specifically kill the RB cells.

Original languageEnglish (US)
Pages (from-to)14396-14401
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume113
Issue number50
DOIs
StatePublished - Dec 13 2016

Fingerprint

Retinoblastoma
Growth Hormone-Releasing Hormone
Hormone Antagonists
Apoptosis
Cryotherapy
Laser Therapy
somatotropin releasing hormone receptor
Combination Drug Therapy
Transcriptome
Genes
Retina
Neoplasms
Epithelial Cells
Cell Proliferation

Keywords

  • Apoptosis
  • GHRH pathway
  • GHRH-R antagonist
  • Growth hormone-releasing hormone
  • Retinoblastoma

ASJC Scopus subject areas

  • General

Cite this

Antagonists of growth hormone-releasing hormone receptor induce apoptosis specifically in retinoblastoma cells. / Chu, Wai Kit; Law, Ka Sin; Chan, Sun On; Yam, Jason Cheuk Sing; Chen, Li Jia; Zhang, Hao; Cheung, Herman S; Block, Norman L; Schally, Andrew V; Pang, Chi Pui.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 113, No. 50, 13.12.2016, p. 14396-14401.

Research output: Contribution to journalArticle

Chu, Wai Kit ; Law, Ka Sin ; Chan, Sun On ; Yam, Jason Cheuk Sing ; Chen, Li Jia ; Zhang, Hao ; Cheung, Herman S ; Block, Norman L ; Schally, Andrew V ; Pang, Chi Pui. / Antagonists of growth hormone-releasing hormone receptor induce apoptosis specifically in retinoblastoma cells. In: Proceedings of the National Academy of Sciences of the United States of America. 2016 ; Vol. 113, No. 50. pp. 14396-14401.
@article{be639762a1584c9bbe4856024bcf3e99,
title = "Antagonists of growth hormone-releasing hormone receptor induce apoptosis specifically in retinoblastoma cells",
abstract = "Retinoblastoma (RB) is the most common intraocular cancer in children worldwide. Current treatments mainly involve combinations of chemotherapies, cryotherapies, and laser-based therapies. Severe or late-stage disease may require enucleation or lead to fatality. Recently, RB has been shown to arise from cone precursor cells, which have high MDM2 levels to suppress p53-mediated apoptosis. This finding leads to the hypothesis that restoring apoptosis mechanisms in RBs could specifically kill the cancer cells without affecting other retinal cells. We have previously reported involvement of an extrapituitary signaling pathway of the growth hormone-releasing hormone (GHRH) in the retina. Here we show that the GHRH receptor (GHRH-R) is highly expressed in RB cells but not in other retinal cells. We induced specific apoptosis with two different GHRH-R antagonists, MIA-602 and MIA-690. Importantly, these GHRH-R antagonists do not trigger apoptosis in other retinal cells such as retinal pigmented epithelial cells. We delineated the gene expression profiles regulated by GHRH-R antagonists and found that cell proliferation genes and apoptotic genes are down- and up-regulated, respectively. Our results reveal the involvement of GHRH-R in survival and proliferation of RB and demonstrate that GHRH-R antagonists can specifically kill the RB cells.",
keywords = "Apoptosis, GHRH pathway, GHRH-R antagonist, Growth hormone-releasing hormone, Retinoblastoma",
author = "Chu, {Wai Kit} and Law, {Ka Sin} and Chan, {Sun On} and Yam, {Jason Cheuk Sing} and Chen, {Li Jia} and Hao Zhang and Cheung, {Herman S} and Block, {Norman L} and Schally, {Andrew V} and Pang, {Chi Pui}",
year = "2016",
month = "12",
day = "13",
doi = "10.1073/pnas.1617427113",
language = "English (US)",
volume = "113",
pages = "14396--14401",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "50",

}

TY - JOUR

T1 - Antagonists of growth hormone-releasing hormone receptor induce apoptosis specifically in retinoblastoma cells

AU - Chu, Wai Kit

AU - Law, Ka Sin

AU - Chan, Sun On

AU - Yam, Jason Cheuk Sing

AU - Chen, Li Jia

AU - Zhang, Hao

AU - Cheung, Herman S

AU - Block, Norman L

AU - Schally, Andrew V

AU - Pang, Chi Pui

PY - 2016/12/13

Y1 - 2016/12/13

N2 - Retinoblastoma (RB) is the most common intraocular cancer in children worldwide. Current treatments mainly involve combinations of chemotherapies, cryotherapies, and laser-based therapies. Severe or late-stage disease may require enucleation or lead to fatality. Recently, RB has been shown to arise from cone precursor cells, which have high MDM2 levels to suppress p53-mediated apoptosis. This finding leads to the hypothesis that restoring apoptosis mechanisms in RBs could specifically kill the cancer cells without affecting other retinal cells. We have previously reported involvement of an extrapituitary signaling pathway of the growth hormone-releasing hormone (GHRH) in the retina. Here we show that the GHRH receptor (GHRH-R) is highly expressed in RB cells but not in other retinal cells. We induced specific apoptosis with two different GHRH-R antagonists, MIA-602 and MIA-690. Importantly, these GHRH-R antagonists do not trigger apoptosis in other retinal cells such as retinal pigmented epithelial cells. We delineated the gene expression profiles regulated by GHRH-R antagonists and found that cell proliferation genes and apoptotic genes are down- and up-regulated, respectively. Our results reveal the involvement of GHRH-R in survival and proliferation of RB and demonstrate that GHRH-R antagonists can specifically kill the RB cells.

AB - Retinoblastoma (RB) is the most common intraocular cancer in children worldwide. Current treatments mainly involve combinations of chemotherapies, cryotherapies, and laser-based therapies. Severe or late-stage disease may require enucleation or lead to fatality. Recently, RB has been shown to arise from cone precursor cells, which have high MDM2 levels to suppress p53-mediated apoptosis. This finding leads to the hypothesis that restoring apoptosis mechanisms in RBs could specifically kill the cancer cells without affecting other retinal cells. We have previously reported involvement of an extrapituitary signaling pathway of the growth hormone-releasing hormone (GHRH) in the retina. Here we show that the GHRH receptor (GHRH-R) is highly expressed in RB cells but not in other retinal cells. We induced specific apoptosis with two different GHRH-R antagonists, MIA-602 and MIA-690. Importantly, these GHRH-R antagonists do not trigger apoptosis in other retinal cells such as retinal pigmented epithelial cells. We delineated the gene expression profiles regulated by GHRH-R antagonists and found that cell proliferation genes and apoptotic genes are down- and up-regulated, respectively. Our results reveal the involvement of GHRH-R in survival and proliferation of RB and demonstrate that GHRH-R antagonists can specifically kill the RB cells.

KW - Apoptosis

KW - GHRH pathway

KW - GHRH-R antagonist

KW - Growth hormone-releasing hormone

KW - Retinoblastoma

UR - http://www.scopus.com/inward/record.url?scp=85006046131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006046131&partnerID=8YFLogxK

U2 - 10.1073/pnas.1617427113

DO - 10.1073/pnas.1617427113

M3 - Article

VL - 113

SP - 14396

EP - 14401

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 50

ER -